Chlamydia jab hope as scientists make breakthrough on treating most common sexually transmitted disease

Mail Online

By Martin Robinson
Last updated at 9:03 PM on 12th October 2011

A vaccine for chlamydia – the most common sexually transmitted disease in Britain – could be developed after a breakthrough by scientists.

For decades experts have been prevented from fully understanding the bacteria, which if undetected can make sufferers infertile.

But now researchers in Southampton have made a significant breakthrough in accessing the chlamydial genome and believe it could pave the way for more effective treatment of the disease.

They hope that it could eventually lead to the development of a vaccine.

There are more than 100,000 known cases in Britain each year – many of them involving men and women under 25.

The infection is part of a silent epidemic as most cases do not show symptoms and are left untreated.

The infection can cause pelvic inflammatory disease and lead to scarring of the fallopian tubes, causing infertility and higher risk of ectopic pregnancy.


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.